Cellular Biomedicine Group, Inc. (CBMG): Buyback News

CBMG – Commences $8.48 mln share repurchase program.


Key Facts Surrounding This News Item


  • CBMG had a POWR Rating of C (Neutral) coming into today.
  • CBMG was -7.82% below its 10-Day Moving Average coming into today.
  • CBMG was -11.90% below its 20-Day Moving Average coming into today.
  • CBMG was -13.49% below its 50-Day Moving Average coming into today.
  • CBMG was -10.29% below its 100-Day Moving Average coming into today.
  • CBMG was -7.16% below its 200-Day Moving Average coming into today.
  • CBMG had returned +56.36% year-to-date leading up to today’s news, versus a +9.11% return from the benchmark S&P 500 during the same period.

More Info About Cellular Biomedicine Group, Inc. (CBMG)


Cellular Biomedicine Group develops treatments for cancerous and degenerative diseases in China. The company was incorporated in 2001 and is based in Palo Alto, California. View our full CBMG ticker page with ratings, news, and more.

Try StockNews.com Premium Today!


Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

CBMG at a Glance

CBMG Current POWR Rating™
Overall POWR Rating™
CBMG Current Price $15.95 3.68%
More CBMG Ratings, Data, and News

CBMG Price Reaction

The day of this event (Oct. 10, 2018)
CBMG Closing Price$17.45 0.80%
CBMG Volume46,800
9.15% from avg
Leading up to this event
CBMG 1-mo return19.13%
After this event
CBMG 1-day return12.18%
CBMG 3-day return8.85%
CBMG 5-day return10.28%

CBMG Price Chart



More Cellular Biomedicine Group, Inc. (CBMG) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CBMG News
Page generated in 0.9991 seconds.